Weight Loss and Inflammation: What the Research Shows

Inflammation is the body's natural response to injury or infection. In the short term, it is protective. But when inflammation becomes chronic — persisting at a low level over months and years — it contributes to a wide range of serious conditions, including cardiovascular disease, type 2 diabetes, certain cancers, and non-alcoholic fatty liver disease.

How does excess weight cause inflammation?

Adipose tissue — body fat — is not simply a passive energy store. It is metabolically active and produces a range of signalling molecules called adipokines. In people with excess body fat, particularly visceral fat stored around the abdominal organs, adipose tissue releases pro-inflammatory cytokines including tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These molecules promote a state of systemic low-grade inflammation.

Visceral fat is particularly problematic because it drains directly into the portal circulation, exposing the liver to high concentrations of inflammatory signals. This contributes to insulin resistance, dyslipidaemia, and non-alcoholic fatty liver disease.

What conditions are linked to obesity-related inflammation?

• Type 2 diabetes — chronic inflammation impairs insulin signalling and accelerates beta-cell dysfunction
• Cardiovascular disease — inflammatory markers such as C-reactive protein (CRP) are elevated in people with obesity and predict cardiovascular risk independently of cholesterol levels
• Osteoarthritis — inflammatory cytokines accelerate cartilage breakdown, compounding the mechanical stress of excess weight on joints
• Certain cancers — chronic inflammation is a recognised driver of colorectal, breast, and endometrial cancers, among others
• Depression — emerging research links elevated inflammatory markers to depressive symptoms, partly explaining the bidirectional relationship between obesity and mental health

Does weight loss reduce inflammation?

Yes — and the effect can be substantial. A 2019 meta-analysis published in Obesity Reviews found that weight loss of 5–10% of body weight significantly reduced circulating levels of CRP, IL-6, and TNF-α. Greater weight loss produced greater reductions in inflammatory markers.

The type of weight loss matters too. Programmes that combine dietary change with physical activity tend to produce larger reductions in visceral fat — and therefore greater anti-inflammatory effects — than dietary restriction alone.

What does this mean in practice?

Reducing inflammation is one of the most important — and often underappreciated — benefits of medically supervised weight loss. Even modest reductions in body weight can meaningfully lower inflammatory burden and reduce long-term disease risk.

To find out whether a doctor-led weight loss programme is right for you, book a consultation with Weight Loss Wales.